On Friday, Quince Therapeutics Inc (NASDAQ: QNCX) was 11.39% up from the session before settling in for the closing price of $3.6. A 52-week range for QNCX has been $0.72 – $3.73.
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.53%. When this article was written, the company’s average yearly earnings per share was at 16.54%. With a float of $48.06 million, this company’s outstanding shares have now reached $54.49 million.
Quince Therapeutics Inc (QNCX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Quince Therapeutics Inc stocks. The insider ownership of Quince Therapeutics Inc is 13.69%, while institutional ownership is 20.78%.
Quince Therapeutics Inc (QNCX) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.28 earnings per share (EPS) during the time that was less than consensus figure (set at -0.1) by -0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.83% during the next five years compared to 7.53% growth over the previous five years of trading.
Quince Therapeutics Inc (NASDAQ: QNCX) Trading Performance Indicators
You can see what Quince Therapeutics Inc (QNCX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.22, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Quince Therapeutics Inc (QNCX)
Looking closely at Quince Therapeutics Inc (NASDAQ: QNCX), its last 5-days average volume was 1.58 million, which is a jump from its year-to-date volume of 0.32 million. As of the previous 9 days, the stock’s Stochastic %D was 89.20%.
During the past 100 days, Quince Therapeutics Inc’s (QNCX) raw stochastic average was set at 89.86%, which indicates a significant increase from 88.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.39 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.05, while its 200-day Moving Average is $1.57. However, in the short run, Quince Therapeutics Inc’s stock first resistance to watch stands at $4.32. Second resistance stands at $4.64. The third major resistance level sits at $4.97. If the price goes on to break the first support level at $3.67, it is likely to go to the next support level at $3.34. Now, if the price goes above the second support level, the third support stands at $3.02.
Quince Therapeutics Inc (NASDAQ: QNCX) Key Stats
There are 55,681K outstanding shares of the company, which has a market capitalization of 223.28 million. As of now, sales total 0 K while income totals -56,830 K. Its latest quarter income was 0 K while its last quarter net income were -13,440 K.
